← Back to Search

Device

BGS goggles for Glaucoma

Phase 1
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over a 3-6 week treatment period to study completion
Awards & highlights

Study Summary

This is an open-label trial of 20 study participants with glaucoma or ocular hypertension. Participants with qualifying study eye(s) after screening and baseline evaluations will receive the Balance Goggles System. After a baseline evaluation (prior to negative pressure application through the BGS), study eyes will be treated for one hour in the clinic and be evaluated again. They will then use the BGS for the next 3-6 weeks and be evaluated again. The goal is to determine whether the intraocular pressure (IOP)-lowering effects of BGS is accompanied by changes in retinal thickness measured by optical coherence tomography (OCT), retinal vascular density measured by OCT-angiography, or retinal fluorescence measured by a fundus camera.

Eligible Conditions
  • Glaucoma
  • Ocular Hypertension

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over a 3-6 week treatment period to study completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and over a 3-6 week treatment period to study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retinal fluorescence
Retinal thickness
Retinal vascular density

Trial Design

1Treatment groups
Experimental Treatment
Group I: BGS useExperimental Treatment1 Intervention
Use of BGS goggles for a 3-6 weeks period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BGS goggles
2019
Completed Phase 1
~20

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,584 Total Patients Enrolled
12 Trials studying Glaucoma
592 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Nevada
How old are they?
18 - 65
What site did they apply to?
Byers Eye Institute at Stanford University
What portion of applicants met pre-screening criteria?
Met criteria
~2 spots leftby Apr 2025